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Sp1
c-JunClaudin-4 is exclusively localized in the tight collecting ducts in the renal tubule. We examined what
molecular mechanism is involved in the regulation of claudin-4 expression. In Madin–Darby canine kidney
cells, hyperosmolarity increased the expression level of claudin-4 and the production of reactive oxygen
species, which were inhibited by diphenyleneiodonium (DPI), an NADPH oxidase inhibitor, and manganese
(III) tetrakis (4-benzoic acid)porphyrin (MnTBAP), a scavenger of H2O2. Both hyperosmolarity and H2O2 in-
creased p-ERK1/2 and p-JNK, which were inhibited by U0126, a MEK inhibitor, and SP600125, a JNK inhibitor,
respectively. Immunoprecipitation assay showed that hyperosmolarity increased the association of nuclear
Sp1 with c-Jun, which was inhibited by U0126 and SP600125. In mouse inner medullary collecting duct
cells and rat kidney slices, hyperosmolarity increased the expression level of claudin-4, which was inhibited
by DPI, MnTBAP, U0126, and SP600125. Hyperosmolarity increased luciferase reporter activity of claudin-4,
which was inhibited by U0126, SP600125, Sp1 siRNA, and c-Jun siRNA. The activity was inhibited by the mu-
tation in the Sp1 binding site. Chromatin immunoprecipitation assay and avidin–biotin conjugated DNA assay
showed that Sp1 and c-Jun are associated with the Sp1 binding site. These results suggest that
hyperosmolarity increases nuclear Sp1/c-Jun complex and the association of the complex with the Sp1 bind-
ing site, resulting in the segment-speciﬁc expression of claudin-4 in the kidney.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Epithelial cells form tight junctions (TJs) that seal adjacent cells in
a narrow band just beneath their apical surface. TJs have multiple
functions such as regulation of paracellular solute and electrical
permeability, maintenance of cell polarity, formation of a paracellular
fence, and separation of cell membrane to apical and basolateral
compartments. TJs are composed of integral membrane proteins and
cytoplasmic plaque proteins [1]. Transmembrane proteins are divided
into two types; four-transmembrane proteins such as claudins,; ChIP, chromatin immunopre-
H, reduced glutathione; H2O2,
, mitogen-activated protein ki-
use inner medullary collecting
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rights reserved.occludin, and tricellulin, and one-transmembrane protein containing
junctional adhesion molecules. Claudins consist of a superfamily of
more than 20 homologous isoforms [2] and these isoforms are
distributed in tissue-speciﬁc pattern [3].
The nephrons of the mammalian kidney can excrete concentrated
urine to conserve water by increasing the tonicity of the medullary
interstitium. The osmotic concentration of urine can exceed
1000 mOsm/kg H2O in the medullary collecting ducts. Hyperosmotic
stress induces reduction in cell volume, DNA breakage, cell cycle
arrest, and restrictions of transcription and translation [4]. Responses
to hyperosmotic stress are essential for cell survival under these
adverse conditions. Cells rapidly initiate a stress signaling cascade
and attempt to restore isotonicity through transport of inorganic
ions and initiate an accompanying reorganization of the actin cyto-
skeleton [5,6]. Integral cell–cell contact is also necessary to maintain
the morphology and function of renal tubule. Hyperosmolarity
increases claudin-4 expression in renal Madin–Darby canine kidney
(MDCK) cell line [7], inner medullary collecting duct cell line, and
mouse kidney [8]. Claudin-4 determines the paracellular charge se-
lectivity. The overexpression of claudin-4 in MDCK cells decreases
2618 A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–2627Na+ permeability without affecting Cl− permeability and mannitol
ﬂux [9]. Furthermore, claudin-4 overexpression enhances the cell–
cell contact [7]. However, it has not been examined what molecules
are involved in the regulation of claudin-4 expression in the kidney.
In the present study, we found that hyperosmolarity increases
claudin-4 expression mediated via an NADPH oxidase-dependent
reactive oxygen species (ROS) production in MDCK cells, mouseHyperosmola
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Fig. 1. Inhibition of hyperosmolarity- and H2O2-induced increase in claudin-4 expressio
hyperosmotic medium (B and E), 500 μM H2O2 (C and F), control medium plus 3 μM cyclo
plus 3 μM CHX (I and L) for the periods indicated. The cell lysate was separated by SDS-PA
densities of claudin-1 (open circles) and claudin-4 (closed circles) were expressed relativ
compared with claudin-1.inner medullary collecting duct cells (mIMCD-3), and rat medullary
collecting ducts. Hyperosmolarity increased nuclear Sp1 and c-Jun
levels, which were inhibited by U0126, a MEK inhibitor, and
SP600125, a JNK inhibitor, respectively. Both U1026 and SP600125
inhibited the hyperosmolarity-induced elevation of claudin-4 expres-
sion and the association of Sp1 and c-Jun with the promoter region of
claudin-4. Hyperosmolarity increased luciferase reporter activity of*
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2619A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–2627claudin-4, which was inhibited by mutation in the Sp1 binding site.
These results indicate that hyperosmolarity increases the expression
level of claudin-4 via production of ROS and the association of
Sp1/c-Jun complex with the Sp1 binding site in the claudin-4 promoter
region.
2. Materials and methods
2.1. Materials
Anti-claudin-1 and claudin-4 antibodies were obtained from
Zymed Laboratories (South San Francisco, CA). Anti-β-actin, AQP2,
p-ERK1/2, and Sp1 antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-ERK1/2 and c-Jun antibodies were from Cell Sig-
naling Technology (Beverly, MA). Anti-JNK, p-JNK, and nucleoporin p62
antibodies were from BD Biosciences Clontech (Franklin Lakes, NJ).BA
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Fig. 2. Involvement of ROS in hyperosmolarity-induced increase in claudin-4 expression. (A
(B) in the presence and absence of 10 mM NAC (N) or 100 μM GSH (G) for 8 h. The cell ly
were incubated with 20 μMH2DCFDA at 37 °C for 60 min. The ﬂuorescence intensity of H2D
of 50 μM DPI (open circles), 250 nM rotenone (closed triangles), or 100 μM allopurinol (ope
were incubated with hyperosmotic medium for 8 h in the absence and presence of rotenone
claudin-1, or β-actin antibody. (E) The ﬂuorescence intensity of H2DCF was measured in h
(open circles) or 500 μM carboxy-PTIO (open triangles). The cells were pre-incubated with
for 8 h in the absence and presence of MnTBAP (M) or carboxy-PTIO (C). The cell lysate w
**P b 0.01 compared with the value in the absence of antioxidants and ROS scavengers.Rotenone andU0126were fromSigma-Aldrich (Saint Louis,MO).Manga-
nese (III) tetrakis (4-benzoic acid)porphyrin (MnTBAP) and SP600125
were from Enzo Life Sciences (Farmingdale, NY). Diphenyleneiodonium
(DPI) was from Cayman Chemical (Ann Arbor, MI). N-acetyl-L-cysteine
(NAC), allopurinol, and reduced glutathione (GSH) were from
Wako Pure Chemical Industries (Osaka, Japan). 2-(4-Carboxyphenyl)-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO) was
from Dojindo laboratories (Kumamoto, Japan). All other reagents
were of the highest grade of purity available.
2.2. Cell culture
Renal MDCK (type II) cells were obtained from European Collection
of Cell Cultures (ECACC No. 00062107, Salisbury, UK). Cells were grown
in Dulbecco's modiﬁed Eagle's medium (Sigma-Aldrich) supplemented
with 5% fetal calf serum (HyClone, Logan, UT), 0.07 mg/ml penicillin-G- + + +
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and B) MDCK cells were incubated with hyperosmotic medium (A) or 500 μM H2O2
sate was immunoblotted with anti-claudin-4, claudin-1, or β-actin antibody. (C) Cells
CF was measured in hyperosmotic medium in the absence (closed circles) and presence
n triangles). The cells were pre-incubated with these antioxidants for 30 min. (D) Cells
(R), DPI (D), or allopurinol (A). The cell lysate was immunoblotted with anti-claudin-4,
yperosmotic medium in the absence (closed circles) and presence of 100 μM MnTBAP
these ROS scavengers for 30 min. (D) Cells were incubated with hyperosmotic medium
as immunoblotted with anti-claudin-4, claudin-1, or β-actin antibody. *P b 0.05 and
2620 A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–2627potassium, and 0.14 mg/ml streptomycin sulfate in a 5% CO2 atmo-
sphere at 37 °C. For the experiments, cells were seeded at a density of
30,000 cells/cm2 on plastic dishes and cultured for 3 days. They were
then incubated with normal (330 mOsm/kg H2O) or hyperosmotic
(550 mOsm/kg H2O) medium for the period indicated. Hyperosmotic
medium was essentially prepared by adding NaCl to the normal
medium. The osmolarity was measured by Osmostat OM-6020 (Kyoto
Daiichi Kagaku, Kyoto, Japan).
2.3. SDS-polyacrylamide gel electrophoresis and immunoblotting
Preparation of cell lysate, SDS-polyacrylamide gel electrophoresis,
and immunoblotting were carried out as described previously [7]. The
protein band density was quantiﬁed with Doc-It LS image analysis
software (UVP, Upland, CA).
2.4. Measurement of intracellular ROS production in MDCK cells
The intracellular production of ROS was detected using the
ﬂuorescent probe H2DCFDA (Molecular Probes, Eugene, OR). MDCK
cells grown on 96-well plates were incubated with Hank's balanced
salt solution (HBSS) containing 20 μM H2DCFDA for 60 min at 37 °C.
After washing twice with HBSS, the cells were exposed to normal or
hyperosmotic (550 mOsm/kg H2O) HBSS for the period indicated.
The ﬂuorescence intensity was measured with excitation at 485 nm
and emission at 538 nm using a Multilabel Counter 1420 ARVOsx
(Perkin Elmer Life and Analytical Sciences).
2.5. Animals and preparation of renal medullary slices
Male Wistar rats (170–230 g, Nippon SLC, Shizuoka, Japan) were
fed standard laboratory chow and allowed free access to drinking
water. Rats were sacriﬁced by cervical dislocation and the kidneyA
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Fig. 3. Inhibition of hyperosmolarity- and H2O2-induced increase in claudin-4, p-ERK1/2
hyperosmotic medium (A) or 500 μM H2O2 (B) for 8 h in the absence and presence of
anti-claudin-4, claudin-1, or β-actin antibody. (C and D) Cells were incubated with hype
U0126 (U), 10 μM SP600125 (S), 10 mM NAC (N), or 100 μM GSH (G). The cell lysate waswas excised. The renal medullary slices (100 μm) were prepared
using a McIlwain Tissue Chopper (Surrey, UK). Then the slices were
incubated with the normal or hyperosmotic (550 mOsm/kg H2O) so-
lution for 3 or 6 h at 37 °C. The normal solution contained 111 mM
NaCl, 5.5 mM glucose, 10 mM Hepes-NaOH, 1.0 mM CaCl2, 1.0 mM
MgCl2, 1.6 mM K2HPO4, 0.4 mM KH2PO4, 24 mM NaHCO3, pH 7.4,
equilibrated with 5% CO2 and 95% O2.
2.6. Immunostaining
MDCK cells were plated at a conﬂuent density on cover glasses.
The cells were ﬁxed with methanol for 10 min at −20 °C, then
permeabilized with 0.2% Triton X-100 for 10 min. After blocking
with 2% Block Ace (Dainippon Sumitomo Pharma, Osaka, Japan) for
30 min, the cells were incubated with anti-Sp1 or c-Jun antibody for
16 h at 4 °C. They were then incubated with Alexa Fluor 488 or
Alexa Fluor 543-conjugated antibody for 1 h at room temperature.
4′,6-Diamidino-2-phenylindole (DAPI) was used for nuclear staining.
Tissue blocks prepared from rat kidney were ﬁxed with 4% parafor-
maldehyde in PBS for 30 min at 4 °C. After the ﬁxed blocks were
cryo-protected in 30% buffered sucrose for overnight, the frozen
sections of 30 μm thickness were cut on a cryostat HM505E (Microm
International, Randburg, Germany). The sections were blocked with
5% goat serum and 2% bovine serum albumin in PBS followed by incu-
bation with anti-claudin-4 and AQP2 antibodies for 3 days at 4 °C.
They were then incubated with Alexa Fluor 488 and Alexa Fluor
543-conjugated antibodies in the pres1ence of DAPI for 1 h at room
temperature. The stained sections were mounted on glass slides.
Images were acquired with an LSM 510 confocal microscope (Carl
Zeiss, Germany) set with a ﬁlter appropriate for DAPI (364 nm excita-
tion, 385–470 nm emission), Alexa Fluor 488 (488 nm excitation,
505–530 nm emission) and Alexa Fluor 543 (543 nm excitation,
560 nm emission).p-JNK
p-ERK1/2
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, and p-JNK by U0126 and SP600125. (A and B) MDCK cells were incubated with
10 μM U0126 (U) or 10 μM SP600125 (S). The cell lysate was immunoblotted with
rosmotic medium (C) or H2O2 (D) for 15 min in the presence and absence of 10 μM
immunoblotted with anti-p-ERK1/2, ERK1/2, p-JNK, or JNK antibody.
2621A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–26272.7. Claudin-4 image quantiﬁcation in rat kidney slices
Using ImageJ software (National Institutes of Health software), the
claudin-4-staining area co-localized with AQP2 was traced and
analyzed in 12 different samples (400 × 400 μm). The intensity of the
claudin-4-derived immunoﬂuorescence was determined by measuring
the mean pixel density of the AQP2-staining area. After subtraction of
background, the intensity values were shown as arbitrary units relative
to control (isotonic condition).H
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A2.8. Quantiﬁcation of ROS production in the kidney slices
The slices were incubated with hyperosmotic medium for 60 min
at 37 °C. Then, they were incubated with 10 μM CellROX Deep Red Re-
agent for 30 min at 37 °C. After setting the slices on glass slides, images
were acquired with an LSM 510 confocal microscope set with a ﬁlter
appropriate for CellROX Deep Red (635 nm excitation, 650–670 nm
emission). The staining area in medullary collecting ducts was traced
and analyzed in 9 different samples (400 × 400 μm). The intensity of
the CellROX Deep Red was determined by measuring the mean pixel
density of staining area. After subtraction of background, the intensity
values were shown as arbitrary units relative to control (isotonic
condition).SP
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D2.9. RNA isolation and quantitative PCR
Total RNA was isolated from MDCK cells and renal medullary slices
using TRI reagent (Sigma-Aldrich). Reverse transcription was carried
out with ReverTra Ace (TOYOBO, Osaka, Japan) and random primers.
Quantitative real time PCR was carried out with Mx3000P Real-Time
PCR System (Agilent Technologies, Santa Clara, CA) using FastStart
universal SYBR Green Master (Roche Applied Sciences, Mannheim,
Germany). The primer pairs of canine claudin-1 (Claudin-1S/Claudin-
1A), canine and rodent claudin-4 (Claudin-4S/Claudin-4A), canine
GAPDH (GAPDH-S/GAPDH-A), and rodent β-actin (β-actin-S/β-actin-
A) were listed on Supplemental Table 1. The threshold cycle (ct) for
each individual PCR product was calculated using the instrument's
software, and ct values obtained for claudin were normalized by
subtracting the ct values obtained for GAPDH or β-actin. The resulting
Δct values were then used to calculate the relative change in mRNA ex-
pression as a ratio (R) of the mRNA expression of hyperosmolarity-
treated samples to themRNA expression of the control samples accord-
ing to the equation R = 2−(Δct(chemical treatment) − Δct(control)).R
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Fig. 4. Inhibition of hyperosmolarity-induced nuclear distribution of Sp1 and c-Jun by
U0126 and SP600125. MDCK cells were incubated with hyperosmotic medium for2.10. Preparation of nuclear fraction and immunoprecipitation
Nuclear fraction was isolated using NE-PER nuclear and cytoplasmic
extraction reagents (Thermo Fisher Scientiﬁc, Rockford, IL). For the
immunoprecipitation assay, the nuclear fraction was incubated with
anti-Sp1 or c-Jun antibody and Protein G-sepharose (GE Healthcare
UK Ltd.) for 16 h at 4 °C with gentle rocking. Negative control was
immunoprecipitated with rabbit IgG. After centrifugation at 6000 ×g
for 1 min, the immune pellets were subjected on SDS-polyacrylamide
gel electrophoresis and immunoblotted with anti-Sp1 and c-Jun
antibodies.30 min in the presence and absence of 10 μM U0126 or 10 μM SP600125. (A) Cells
were double stained with DAPI (blue) and anti-Sp1 (green) or c-Jun (red) antibody.
The scale bar represents 10 μm. (B) Nuclear proteins were prepared from the cells and
were immunoblotted with anti-c-Jun, Sp1, or nucleoporin p62 antibody. (C) Nuclear
proteins were immunoprecipitated with anti-Sp1 or c-Jun antibody. Then the immune
pellets were immunoblotted with anti-c-Jun or Sp1 antibody. (D) Cells were incubated
with hyperosmotic medium in the absence and presence of 10 μM U0126 or 10 μM
SP600125 for 3 h. Quantitative RT-PCR was performed using the speciﬁc primers for
claudin-1, claudin-4, and GAPDH. Claudin-1 and claudin-4mRNA levels were normalized
to GAPDH level and represented as the fold increase over control. **P b 0.01 compared
with control. ##P b 0.01 compared with hyperosmolarity.2.11. RNA interference
Sp1 and c-Jun siRNAs were produced by Sigma-Aldrich. The
oligoribonucleotides of Sp1 and c-Jun were 5′-CCAACAGAUCAUCACA
AAUTT-3′ and 5′-GGCACAGCUUAAACAGAAATT-3′, respectively. Cells
were transfected with these siRNAs or control siRNA (Fluorescein
Conjugate-A, Santa Cruz) using HilyMax (Dojindo laboratories).2.12. Luciferase reporter assay
The promoter region of the canine claudin-4 gene [XP_003639125]
was subcloned into the pGL4.10 (luc2) vector (Promega) upstream
of a luciferase reporter gene. The fragment of 2006 bp was ampliﬁed
by PCR using a set of primer−2081S/−76A (Supplemental Table 1).
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2623A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–2627The deletion fragments of 1015, 520, and 258 bp were ampliﬁed
using a set of primer −1090S/−76A, −595S/−76A, and −333S/
−76A, respectively. A Renilla construct, pRL-TK vector (Promega),
was used for normalizing transfection efﬁciency. Cells were
transfected with plasmid DNA using HilyMax. After 48 h of transfec-
tion, luciferase activity was assessed using the Dual-Glo Luciferase
Assay System (Promega). Hyperosmolarity was treated at the ﬁnal 8 h
before the luciferase assay. The luminescence of the Fireﬂy and Renilla
luciferase was measured with a Luminescencer Octa AB-2270 (Atto,
Tokyo, Japan). Relative promoter activity was represented as the fold-
increase compared to the promoterless pGL4.10 vector. The mutants
of AP-1 binding sites (−470/−462 and−379/−371) and Sp1 binding
sites (−508/−499 and −427/−418) were generated using a Quick
Change site-directedmutagenesis kit (Agilent Technologies). The prim-
er pairswere AP-M1S/AP-M1A, AP-M2S/AP-M2A, Sp-M1S/Sp-M1A, and
Sp-M2S/Sp-M2A.
2.13. Chromatin immunoprecipitation (ChIP) assay
Cellswere treatedwith 1% formaldehyde to crosslink the protein to
the DNA. Then, ChIP assay was performed using a ChIP-IT Express
Enzymatic Kit (Active Motif, Carlsbad, CA) as recommended by the
manufacturer's instructions. To co-immunoprecipitate the DNA, anti-
Sp1 and c-Jun antibodies were used. The eluted DNA was ampliﬁed
by PCR using the primer pairs −540S/−310A or −2076S/−1930A
(Supplemental Table 1). To conﬁrm the same amounts of chromatins
used in immunoprecipitation between groups, input chromatin was
also used. The PCR products (231 and 207 bp) were visualized with
ethidium bromide after electrophoretic separation on a 2% agarose
gel. Immunoprecipitation using rabbit IgG was carried out as a nega-
tive control.
2.14. Avidin–biotin conjugated DNA (ABCD) assay
The following double-stranded oligonucleotides were used. All
biotinylated at the 5′-end of the sense strand, wild-type Sp1: 5′-GCAT
GGGCCTGGGGGCTGGGAGACAGGGCAGT-3′, mutant Sp1: 5′-GCATGGG
CCTGGGCCCCGGGAGACAGGGCAGT-3′, and wild-type AP-1: 5′-GCCTG
TGGTCTGTGACTCAGTGTCTTTCTCC-3′. An ABCD assay was performed by
incubating nuclear extracts derived from the hyperosmolarity-treated
cells with double-stranded DNA immobilized on streptavidin agarose
in a binding buffer (80 mM KCl, 1 mM MgCl2, 0.2 mM EDTA, 0.5 mM
dithiothreitol, 10% glycerol, 0.1% Triton X-100, 20 mM Hepes-KOH
(pH 7.9), a protease inhibitor cocktail and 1 mM phenylmethylsulfonyl
ﬂuoride). After 16 h of incubation at 4 °C, the beads were washed four
times with the binding buffer and proteins were subjected on SDS-
polyacrylamide gel electrophoresis.
2.15. Statistics
Results are presented as the mean ± S.E.M. Differences between
groups were analyzed with a one-way analysis of variance, and correc-
tions for multiple comparison were made using Tukey's multiple
comparison test. Comparisons between two groups were made using
Student's t test. Signiﬁcant differences were assumed at P b 0.05.Fig. 5. Increases in claudin-4 expression and ROS production by hyperosmolarity in rat ren
medium in the absence and presence of 10 mM NAC, 100 μM GSH, 50 μM DPI, 100 μM M
anti-claudin-4 (green) and AQP2 (red) antibodies. The right panels show merged ima
claudin-4-staining area co-localized with AQP2 was traced using ImageJ. The mean inte
(C) Renal slices were incubated with hyperosmotic medium in the absence and presence of
RT-PCR was performed using the speciﬁc primers for rodent claudin-4 and β-actin. Claudin-
control (isotonic condition) (D) The slices were incubated with hyperosmotic medium in t
incubated with 10 μM CellROX Deep Red Reagentat for 30 min. The mean ﬂuorescence int
condition). **P b 0.01 compared with control. ##P b 0.01 compared with hyperosmolarity.3. Results
3.1. Effects of hyperosmolarity and H2O2 on expression level of claudin-4
Hyperosmotic NaCl medium increased the expression level of
claudin-4 protein in a time-dependent manner but not claudin-1
protein in MDCK cells (Fig. 1B and E). A part of cells were detached
from the culture dishes by hyperosmolarity and the cellular injury
was 10.9 ± 1.2% (n = 4) at 8 h. In normal medium, the levels of
claudin-4 and claudin-1 were unchanged within 8 h (Fig. 1A and D).
H2O2 also increased the expression level of claudin-4 protein
but not claudin-1 protein (Fig. 1C and F). In immunoﬂuorescence
measurements, claudin-4 was distributed in the TJs together with
ZO-1 (Supplementary Fig. 1). Claudin-4 remained localized at
the TJs after treatment with hyperosmolarity and H2O2. In control,
hyperosmotic, and H2O2 treatments, the expression levels of claudin-4
and claudin-1 were decreased by cycloheximide, a translational inhibi-
tor (Fig. 1G–L). These results suggest that both hyperosmolarity and
H2O2 increase claudin-4 protein without affecting its stability.
3.2. Inhibition of hyperosmolarity- and H2O2-induced claudin-4 elevation by
NADPH oxidase inhibitor and H2O2 scavenger
The hyperosmolarity- and H2O2-induced increase in claudin-4
expression was inhibited by antioxidants, NAC and GSH, in MDCK
cells (Fig. 2A and B). To determine how hyperosmotic NaCl increases
claudin-4 expression, media osmolarity was increased with either
urea or mannitol. Similar to NaCl, hyperosmotic mannitol and urea in-
creased claudin-4 expression (Supplementary Fig. 2A and B). These
results indicate that the elevation of osmolarity of the surrounding
ﬂuid, rather than the addition of a particular solute, increases
claudin-4 expression. Next, we examined whether NADPH oxidase,
xanthine oxidase, and mitochondrial electron transport system are
involved in the mechanism of ROS production. In the H2DCF-loaded
cells, the ﬂuorescence intensity was increased by hyperosmotic
NaCl, mannitol, and urea media (Fig. 2C and Supplementary Fig. 2C).
The increase in ﬂuorescence intensity was inhibited by DPI, an
NADPH oxidase inhibitor, but not by rotenone, a mitochondria inhib-
itor, and allopurinol, a xanthine oxidase inhibitor (Fig. 2C). Similarly,
the hyperosmolarity-increased claudin-4 expression was inhibited by
DPI, but not by rotenone and allopurinol (Fig. 2D). These results
suggest that the hyperosmolarity-induced effects are mediated via an
NADPH oxidase-dependent ROS production. Next, we examined the
effects of ROS scavengers on the hyperosmolarity-increased claudin-4
expression. The hyperosmolarity-dependent ROS production was
inhibited by MnTBAP, a scavenger of H2O2, but not by cPTIO, a scaven-
ger of nitric oxide (Fig. 2E). Similarly, the hyperosmolarity-increased
claudin-4 expression was inhibited by MnTBAP, but not by cPTIO
(Fig. 2F). Therefore, H2O2 is suggested to be a major component of
ROS in this mechanism.
3.3. Increase in p-ERK1/2 and p-JNK levels by hyperosmolarity and H2O2
ROS can activate mitogen-activated protein (MAP) kinase includ-
ing c-Jun N-terminal kinase (JNK), p38, and ERK1/2 [10]. The
hyperosmolarity- and H2O2-increased claudin-4 expression wasal collecting ducts (A) Tissue blocks of rat kidney were incubated with hyperosmotic
nTBAP, 10 μM U0126, or 10 μM SP600125 for 6 h. Tissue sections were stained with
ges of claudin-4, AQP2, and DAPI (blue). The scale bar represents 10 μm (B) The
nsity values were shown as arbitrary units relative to control (isotonic condition).
NAC, GSH, DPI, MnTBAP, U0126, or SP600125 for 3 h. After isolating RNA, quantitative
4 mRNA level was normalized to β-actin level and represented as the fold increase over
he absence and presence of NAC, GSH, DPI, MnTBAP for 60 min. Then, the slices were
ensity (in arbitrary units) was represented as the fold increase over control (isotonic
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pGL4.10 vector. Four promoter luciferase constructs were co-transfected with the
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in MDCK cells (Fig. 3A and B). Since these results suggest involve-
ment of two pathways (ERK1/2 and JNK), we examined whether
hyperosmolarity and H2O2 increase p-ERK1/2 and p-JNK levels. As
expected, hyperosmolarity and H2O2 increased p-ERK1/2 and p-JNK
levels, which were inhibited by U0126 and SP600125, respectively,
and both of them were inhibited by NAC and GSH (Fig. 3C and D).
ERK1/2 and JNK levels were unchanged by the treatments with
hyperosmolarity, H2O2, U0126, SP600125, NAC, and GSH. Next, we
examined the effect of hyperosmolarity on either side or both
sides of the epithelial cells. When basolateral osmolarity increased,
p-ERK1/2 and p-JNK levels were unchanged (Supplementary
Fig. 3). In contrast, application of hyperosmolarity to the apical and
both sides increased p-ERK and p-JNK levels. These results suggest
that hyperosmolarity-dependent ROS production increases the
claudin-4 level via activation of ERK1/2 and JNK pathways from the
apical side.
3.4. Effects of MAP kinase inhibitors on hyperosmolarity-induced
increase in Sp1, c-Jun, and claudin-4 expression
Two of the downstream targets of ERK1/2 and JNK are Sp1 and
c-Jun, respectively. Immunostaining and Western blotting of sub-
cellular fractionated samples showed that hyperosmolarity increased
nuclear distribution of Sp1 and c-Jun, which was inhibited by U1026
and SP600125, respectively (Fig. 4). Furthermore, hyperosmolarity
increased the association of Sp1 with c-Jun, which was inhibited by
U0126 and SP600125. Both U0126 and SP600125 inhibited the
hyperosmolarity-induced increase in claudin-4 mRNA level without
affecting claudin-1 mRNA. These results suggest that both Sp1
and c-Jun are involved in the up-regulation of claudin-4 expression
under the hyperosmotic conditions.
3.5. Increase in claudin-4 expression by hyperosmolarity in rat medullary
collecting ducts
We examinedwhether the regulatory mechanisms found inMDCK
cells are signiﬁcant in rat kidney and mIMCD-3 cells. In Fig. 5A, AQP2,
a marker of collecting ducts, was found to be co-localized with
claudin-4. Hyperosmolarity increased expression level of claudin-4
protein, and the increase was inhibited by NAC, GSH, DPI, MnTBAP,
U0126, and SP600125 (Fig. 5B). Real-time PCR revealed that
hyperosmolarity increases claudin-4 mRNA level (Fig. 5C). This in-
crease was also inhibited by NAC, GSH, DPI, MnTBAP, U0126, and
SP600125. Actually, hyperosmolarity-induced ROS production, which
was inhibited by NAC, GSH, DPI, and MnTBAP, could be detected
(Fig. 5D). Similarly, hyperosmolarity increased ROS production and
claudin-4 mRNA level, which were inhibited by NAC, GSH, DPI, MnTBAP,
U0126, and SP600125 in mIMCD-3 cells (Supplementary Fig. 4). These
results suggest that a series of hyperosmolarity-induced events found
in MDCK cells seems to be functional, at least, in medullary collecting
ducts in the kidney.
3.6. Inhibition of promoter activity of claudin-4 by U0126 and SP600125
To examine the effects of U0126 and SP600125 on the transcription-
al activity of claudin-4, we measured promoter activity of claudin-4.
In the constructs of −2081/−76, −1090/−76, and −595/−76,
hyperosmolarity signiﬁcantly increased the promoter activity, which
was equally inhibited by U0126 and SP600125 (Fig. 6A). In contrast,
hyperosmolarity had no effect on the promoter activity in the construct
of −333/−76. These results suggest that hyperosmolarity-sensitive
region exists between−595 and−334. This region contains two puta-
tive Sp1 and AP-1 binding sites. Four mutants were prepared using
Quick Change mutagenesis kit and named as Sp-M1, Sp-M2, AP-M1,
and AP-M2, respectively. In the constructs of Sp-M1, AP-M1, andAP-M2, hyperosmolarity increased the reporter activity (Fig. 6B). In
contrast, hyperosmolarity had no effect on the promoter activity in
the construct of Sp-M2, suggesting that the proximal Sp1 binding site
is essential for function of transcriptional factors.
3.7. Association of Sp1/c-Jun complex with claudin-4 promoter region
Introduction of Sp1 or c-Jun siRNA decreased the expression levels of
Sp1 and c-Jun, respectively (Fig. 7A). Both siRNAs decreased claudin-4
protein level without affecting claudin-1 expression (Fig. 7B). Further-
more, both siRNAs inhibited the hyperosmolarity-induced increase in
promoter activity (Fig. 7C). These results reinforce the notion that both
Sp1 and c-Jun are involved in the hyperosmolarity-induced increase
in claudin-4 expression. In the ChIP assay, a primer pair of −540S/
−310A containing the proximal Sp1 binding site showed positive PCR
signals in the hyperosmolarity-treated cells using anti-Sp1 or c-Jun
antibody (Fig. 8A). In contrast, a primer pair of −2076S/−1930A,
which ampliﬁes a sequence about 1500 bases upstream from Sp1 bind-
ing site, showed no positive signals. In the hyperosmolarity plus
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Fig. 7. Inhibition of hyperosmolarity-induced increase in claudin-4 and its promoter activity by c-Jun or Sp1 siRNA. (A and B) Nuclear proteins (A) and cell lysates (B) were prepared
from the cells expressing negative (N), c-Jun (J), or Sp1 (S) siRNA, and immunoblotted with anti-c-Jun, Sp1, nucleoporin p62, claudin-1, claudin-4, or β-actin antibody. (C) The
pGL4.10 vector containing the 5′-ﬂanking regions of canine claudin-4 from −595 to −76 was co-transfected into the cells with negative (N), c-Jun (J), or Sp1 (S) siRNA. After
40 h of transfection, the cells were incubated with normal (open columns) or hyperosmotic (closed columns) medium for 8 h. Data represent means ± S.E.M. of 3 experiments.
*P b 0.05 compared with normal medium. #P b 0.05 compared with negative siRNA.
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anti-Sp1 or c-Jun antibody. Using rabbit IgG, neither −540S/−310A
nor −2076S/−1930A produced PCR signals. These results indicate
that Sp1 and c-Jun function cooperatively to the promoter region of
claudin-4. Next, we performed an ABCD assay using biotin conjugated
double-strand oligonucleotides that contain wild type or mutant Sp1
binding site (Fig. 8B). The oligonucleotide containing wild type Sp1
binding site bound to both Sp1 and c-Jun (Fig. 8C). In contrast, the oligo-
nucleotide containing mutant Sp1 or wild type AP-1 binding site bound
to neither Sp1nor c-Jun. Therefore, Sp1/c-Jun complexmaybe associated
with the Sp1 binding site of claudin-4 promoter region. A putative
scheme for the up-regulation of claudin-4 expression by hyper-
osmolarity is depicted in Fig. 9.IgG
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or wild type of AP-1 (A) binding site. Input (I) was loaded in the left lane. The proteins we4. Discussion
The current studies demonstrate that ROS-dependent activation of
MAP kinase pathways is involved in the hyperosmolarity-induced in-
crease in claudin-4 expression in the kidney. Analysis of the molecular
mechanisms by which hyperosmolarity induces nuclear distribution
of Sp1 and c-Jun has identiﬁed important roles for the transcriptional
regulation of claudin-4. Within the kidney, claudin-4 expression is
restricted to the thin ascending limb of Henle's loop and collecting
ducts where a high osmolarity in the interstitial ﬂuid of the kidney is
maintained [11,12]. Clostridium perfringens enterotoxin (CPE) fragment
binds to claudin-4 and decreases claudin-4 expression in MDCK cells,
resulting in the disruption of the TJs barrier in epithelial cell sheetsc-Jun
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Fig. 9. A putative scheme for increase in claudin-4 expression by hyperosmolarity. Hyperosmolarity increases ROS production mediated via NADPH oxidase. Hyperosmolarity and
H2O2 increase p-ERK1/2 and p-JNK levels, which are inhibited by U0126 and SP600125, respectively. The U0126-sensitive pathway increases nuclear Sp1 level, whereas the
SP600125-sensitive pathway increases nuclear c-Jun level. The Sp1/c-Jun complex binds to the proximal Sp1 binding site in the claudin-4 promoter region and increases the
transcriptional activity.
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panied by an increase in claudin-4 expression, indicating that claudin-4
plays a critical role in the maintenance of TJ integrity. We recently
reported that claudin-4 enhances cell–cell contact in MDCK cells
[7]. Claudin-4 expression is increased by hyperosmotic stress in
MDCK cells [7], mechanical stress in alveolar epithelial cells [14],
and ventilator-induced lung injury in mice [15]. Claudin-4 may have a
role in the survival and adaptation of the cells to the high-stress
environments.
Intracellular ROS production was increased by hyperosmotic NaCl,
mannitol, and urea media (Fig. 2C and Supplementary Fig. 2C). Similar
results are reported in renal tubular mIMCD-3 cells [16] and LLC-PK1
cells [17]. Twomajor sources of ROS in the renalmedulla are NADPHox-
idase and mitochondria [18]. We found that hyperosmolarity-induced
production of ROS and elevation of claudin-4 expression are inhibited
by DPI, an NADPH oxidase inhibitor, and MnTBAP, a H2O2 scavenger,
in MDCK cells, mIMCD-3 cells, and rat renal medulla (Figs. 2 and 5
and Supplementary Fig. 2). These results suggest that NADPH oxidase-
dependent ROS production, especially H2O2, is involved in the up-
regulation of claudin-4 expression by hyperosmolarity in the kidney.
In the hyperosmotic conditions, NADPH oxidase-dependent ROS
production is also reported in the hepatocytes [19] and neutrophil
cells [20]. In contrast, Yang et al. [21] reported that hyperosmolarity-
induced production of ROS and activation of cyclooxygenase II are
inhibited by rotenone, a mitochondria inhibitor, in mIMCD-K2 cells.
They suggested that hyperosmolarity-induced responses are activated
by ROS derived from mitochondria, because the responses remain in
IMCD cells deﬁcient in either gp91phox or p47phox, subunits of NADPH
oxidase. However, their data show that the activation of cyclooxygenase
II is inhibited by DPI, an NADPH oxidase inhibitor. NADPH oxidase-
dependent ROS production may be involved in hyperosmolarity-
induced responses in the kidney.
Little is known about the transcriptional regulatory mechanism of
claudin-4. ROS can activate MAP kinase cascade including JNK, p38,and ERK1/2 followed by the activation of transcriptional factors such
as c-Fos, c-Jun, Sp1, and NF-κB [22]. The hyperosmolarity-induced in-
crease in claudin-4 expression was inhibited by U0126 and SP600125
in the same level (Figs. 4D, 5B and C, and Supplementary Fig. 4B).
U0126 decreased p-ERK1/2 and nuclear Sp1 levels, but did not decrease
p-JNK and nuclear c-Jun levels. In contrast, SP600125 decreased p-JNK
and nuclear c-Jun levels. We recently reported that nuclear localization
of Sp1 is involved in the up-regulation of claudin-4 caused by the acti-
vation of a MEK/ERK pathway [23], but no evidence shows that Sp1
binds to the claudin-4 promoter in renal tubular cells. Furthermore, it
has not been examined whether c-Jun is involved in the regulation of
claudin-4 expression. Here, we clariﬁed that the knockdown of Sp1 or
c-Jun inhibits hyperosmolarity-induced increase in claudin-4 expres-
sion (Fig. 7). Using micro-serial analysis of gene expression technique,
Uawithya et al. [24] reported that Sp1 and c-Jun are expressed in the
collecting ducts of rat kidney. We suggest that both Sp1 and c-Jun are
involved in the up-regulation of claudin-4 expression under the
hyperosmotic conditions in the collecting ducts.
Claudin-4 is endogenously expressed in human ovarian cancer
cells, which is decreased by Sp1 knockdown [25]. The binding site of
Sp1 located on human claudin-4 promoter in position between −65
and −43. In contrast, we found that the hyperosmolarity-sensitive
binding site of Sp1 locates between −595 and −334 in canine
claudin-4 promoter. Hyperosmolarity did not increase the promoter
activity in the construct of−333/−76 and mutant of Sp-M2 (Fig. 6).
Furthermore, a primer pair of −540S/−310A showed positive PCR
signals in ChIP assay (Fig. 8). Sp1 is also involved in the regulation of
other claudins such as claudin-1 [26], claudin-3 [27], and claudin-19
[28]. Interactionwith other protein factorsmay be one of themost im-
portant activation of Sp1 [29]. However, it has not been examined
what binding partner of Sp1 is involved in the regulation of claudins
expression.
To clarify whether Sp1 and c-Jun function cooperatively, we
performed luciferase reporter assay, immunoprecipitation experiments,
2627A. Ikari et al. / Biochimica et Biophysica Acta 1833 (2013) 2617–2627and ABCD assay. The promoter region between−595 and−334 in ca-
nine claudin-4 promoter contains two putative Sp1 and AP-1 binding
sites. Only one mutation of proximal Sp1 binding site (Sp-M2) inhibited
the hyperosmolarity-increased promoter activity (Fig. 6B). We suggest
that c-Jun is the binding partner of Sp1 and the Sp1/c-Jun complex is
associated with the proximal Sp1 binding site. This concept is supported
by these ﬁndings: (1) claudin-4 expression in the U0126-treated cells is
similar to that in the SP600125-treated cells, (2) hyperosmolarity in-
creased the association of Sp1 with c-Jun, (3) hyperosmolarity-induced
elevation of claudin-4 expression and the association of c-Jun and Sp1
with the promoter region of canine claudin-4 were inhibited by U0126
or SP600125 in spite of either c-Jun or Sp1 exists in the nuclei. The
cooperation of Sp1 and c-Jun is reported in several gene expression
such as 12(S)-lipoxygenase [30], neuronal nicotinic acetylcholine recep-
tor β4 [31], cytosolic phospholipase A2 [32], and atrial natriuretic factor
[33]. The different binding afﬁnity of Sp1/c-Jun to the Sp1 binding site
and AP-1 binding site might be caused by stereo-recognition of complex
to the Sp1 binding sequence but not AP-1 binding sequence in the
claudin-4 promoter region.
In conclusion, we found that hyperosmolarity increases claudin-4
expression mediated via the NADPH oxidase-dependent ROS
production in MDCK cells, mIMCD-3 cells, and rat collecting ducts.
Hyperosmolarity and H2O2 increased p-ERK and p-JNK levels,
resulting in the elevation of nuclear Sp1 and c-Jun levels, respective-
ly. The Sp1/c-Jun complexwas associated with Sp1 binding site of ca-
nine claudin-4 promoter region. Our data suggest that the activation
of the MEK/ERK/Sp1 and JNK/c-Jun signaling pathways is involved in
the hyperosmolarity-induced increase in claudin-4 expression in
renal collecting ducts. Claudin-4 may have a role in maintaining
the structure of medullary collecting ducts to protect renal tubule
against hyperosmotic stress.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.06.016.References
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